Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome

Xin Gu, Jasminka Dragovic, Gloria C. Koo, Sam L. Koprak, Cheryl B. LeGrand, Steven S. Mundt, Kashmira Shah, Marty S. Springer, Eugene Y. Tan, Rolf Thieringer,

Bioorganic & Medicinal Chemistry Letters · 2005 · 54 citations · 14 references

DOIFull text

Open access

Concepts

References

14